Essential Partners’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
LAM
CFS
FFO
Essential Partners's PLSE Position: Q3 2026 in Review
Essential Partners held its Pulse Biosciences (PLSE) position steady in Q3 2026 at 5 shares worth $250. The position accounts for ﹤0.01% of the portfolio, ranked #2548.
Essential Partners first reported a position in PLSE in Q2 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Essential Partners held 5 shares of Pulse Biosciences worth $250 as of Q3 2026.
- Essential Partners left its Pulse Biosciences share count unchanged in Q3 2026.
- Pulse Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2548 holding.
- Essential Partners first reported a position in Pulse Biosciences in Q2 2026 and has held it in 2 quarters since.
- 8 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.